No one likes the “B” word, but it’s worth asking whether we’re seeing one in large-cap biotech stocks right now.Source: ©iStock.com/AlexRathsAt first glance, it seems to be a legitimate question given how well the sector has performed in the past year. The iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) has gained nearly 70% since the low of mid-April 2014, and it […]
Billionaire Seth Klarman is a notorious investor who despite his uncoventional approaches always managed to achieve high returns. He founded Baupost Group in 1982 with around $30 million and since then the hedge fund grew to one of the biggest in the world and currently manages over $28 billion in assets. Mr. Klarman is very secretive about his strategies, which […]
View All3 Biotech Stocks That Could Pop in a HeartbeatBiotech stocks have been on a tear lately, with the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) outrunning the S&P 500 about 45% to 10% over the past 10 months.Click to Enlarge And momentum still is on biotechs’ side, with 57% of the XBI’s components trading above their respective 50-day moving average. For […]
The bull market turned six-years-old this week, which is pretty amazing. It’s been quite a ride. In that time, the Dow Jones Industrial Average has charged ahead more than 150%, the S&P 500 180% and Nasdaq 250%. One group that has been at the forefront of this bull market is biotech stocks.Source: FlickrIn fact, the past five years have been […]
Gilead, without a doubt, has proven itself to be a leader in the biotechnology industry. The stock has had an extremely bullish pattern over the last four years, growing over 400% in stock price since March 2011. However, over the last 6 months, the stock has seen a loss of about 5%.In fact, there has been a considerable amount of […]
The Nasdaq composite remains heavily weighted toward technology, thanks to Apple’s record market valuation near $750 billion. But tech’s weighting is down sharply from the Nasdaq’s peak, while the financial, consumer services and health-care sectors have seen their weightings more than double within the composite. [See table below.]Health care’s weighting in the composite is now 16 percent, which is comparable […]
The Seven Financial Indicators of Highly Successful Biotech Stocks InvestingCompanies / BioTechFeb 21, 2015 – 10:41 AM GMTBy: Money_MorningErnie Tremblay writes: When evaluating biotech stocks, many key indicators that work for other industries – e.g. price-to-earnings ratio, profit margin, revenue-per-share – often don’t apply.Here’s why they don’t, and why seven of these critical financial indicators do…The Usual Ratios Don’t ApplyThe […]
You may have already been aware that the biotechnology sector has been hot over the past several years. But have you seen it lately? While most other sectors have been trending sideways, or even down as in the case of energy, the biotechnology sector has been absolutely on fire – with the largest biotech ETF iShares Nasdaq Biotechnology (NASDAQ: IBB) […]
For some time now, Europe’s economy has been traversing rough waters. Economic data has been disappointing and geopolitical tensions have kept investors worried. While an uneasy truce has been reached on Ukraine, Greece debt negotiations remain unresolved. But new economic data and stock market performance indicate that it may a good time to buy into Europe after all.Markets Moving NorthMarkets […]
SummaryHot = near-term stock price gain potential, not just product developments, lab breakthroughs, corporate acquisitions, financing deals, trial progresses etc.
Only opinions; not even “just the facts, m’aam”. But opinions expressed by folks who need to know, willing to put their money at risk, based on what they know.
Maybe even better, ones who are willing to pay up for price-change risk […]
